Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 29, 2025 21:24 ET | Source: Prostadine

Prostadine Drops Ingredient Analysis 2026: Examining the Science Behind the Liquid Prostate Wellness Formula

New 2026 analysis examines Prostadine drops' nine marine-derived ingredients, iodine content, saw palmetto research, and safety considerations for men.
December 24, 2025 09:30 ET | Source: Westhaven Gold Corp.

Westhaven Announces Grant of Incentive Stock Options and Peterson Capital Engagement

VANCOUVER, British Columbia, Dec. 24, 2025 (GLOBE NEWSWIRE) -- Westhaven Gold Corp. (TSX-V: WHN) (“Westhaven” or the “Company”) announces that, pursuant to the terms of the Company's Stock Option...
December 24, 2025 09:15 ET | Source: Clearmind Medicine Inc.

Clearmind Medicine Reflects on a Transformative 2025: Key Clinical Advancements, Expanded Global Reach, and Strengthened Foundation for Future Growth

Vancouver, Canada, Dec. 24, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery...
December 22, 2025 16:35 ET | Source: HUMBL, Inc.

U.S. District Court Dismisses Securities Class Action Against HUMBL, Inc.

San Diego, California, Dec. 22, 2025 (GLOBE NEWSWIRE) -- HUMBL, Inc. (OTC: HMBL) today announced that the United States District Court for the District of Delaware has dismissed, with prejudice, the...
December 22, 2025 08:00 ET | Source: Oryzon Genomics, S.A.

ORYZON Expands Global Patent Protection for Iadademstat with Grant Decision in Japan Covering Combinations with PD-1/PD-L1 Inhibitors

MADRID and CAMBRIDGE, Mass., Dec. 22, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and global leader in epigenetics,...
December 22, 2025 07:00 ET | Source: Westhaven Gold Corp.

Westhaven and Dundee Corporation Sign Definitive $85 Million Earn-In Agreement to Advance Shovelnose and the Spences Bridge Gold Belt, British Columbia

VANCOUVER, British Columbia, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Westhaven Gold Corp. (TSX-V: WHN) (“Westhaven” or the “Company”) and Dundee Corporation (TSX: DC.A) (“Dundee”) are pleased to announce...
December 17, 2025 09:59 ET | Source: Burn Tucker Lachaîne P.C.

Burn Tucker Lachaîne P.C. Expands Focus on Disability Claims Amid Surge in Autoimmune Disease in Canada

Ottawa, Ontario, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Burn Tucker Lachaîne P.C., a leading injury and disability law firm, is expanding its focus on long-term disability claims involving autoimmune...
December 17, 2025 09:03 ET | Source: Mothers' Milk Bank California

Mothers’ Milk Bank California and Johns Hopkins School of Medicine Launch Research Partnership to Advance Understanding of Donor Human Milk on Babies in Need

MMBCA and Johns Hopkins School of Medicine launch a research partnership to study donor human milk’s bioactive properties and improve NICU outcomes.
December 17, 2025 08:34 ET | Source: PaymentWorks

PaymentWorks Announces Award Winners During Third Annual Vendor Management Appreciation Day Event

WALTHAM, Mass., Dec. 17, 2025 (GLOBE NEWSWIRE) -- PaymentWorks today announced the 2025 winners of the Vendor Management Appreciation Day customer awards during a live virtual event. Vendor...
December 16, 2025 08:45 ET | Source: Clearmind Medicine Inc.

Clearmind Medicine Announces Successful Completion of Second Cohort Enrollment in Ongoing FDA-Approved Phase I/IIa Trial for CMND-100

Vancouver, Canada, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and...